Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-012691

Head of Development sold 91 shares at $277.11 ($25,217)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Singhal Priya Head of Development 2023-04-04 Sale 10b5-1 −91 $277.11 $25,217 2,843.09 D: show line 1 in the form
Open-market sales · 91 sh · avg $277.11 · $25,217
Loading xslF345X04/form4.xml…